[
    [
        {
            "time": "2023-04-08",
            "original_text": "Large-Cap Pharma Stocks to Benefit in Post-Pandemic Market AbbVie Stock Rises 3% Top Ranked Income Stocks to Buy for April 8th Is AbbVie Stock A Buy Amid The Ongoing Coronavirus Pandemic?",
            "features": {
                "keywords": [
                    "AbbVie",
                    "pharma",
                    "post-pandemic",
                    "income stocks",
                    "coronavirus"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Large-Cap Pharma Stocks to Benefit in Post-Pandemic Market AbbVie Stock Rises 3% Top Ranked Income Stocks to Buy for April 8th Is AbbVie Stock A Buy Amid The Ongoing Coronavirus Pandemic?",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-04-08",
            "original_text": "The Zacks Analyst Blog Highlights: Procter & Gamble, AbbVie, QUALCOMM, PepsiCo and CME Group The Zacks Analyst Blog Highlights: AbbVie, Coherus BioSciences, Bluerock Residential Growth REIT, Huntington Ingalls Industries and Installed Building Products",
            "features": {
                "keywords": [
                    "Zacks",
                    "analyst blog",
                    "AbbVie",
                    "Procter & Gamble",
                    "QUALCOMM",
                    "PepsiCo",
                    "CME Group"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "diversified"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "The Zacks Analyst Blog Highlights: Procter & Gamble, AbbVie, QUALCOMM, PepsiCo and CME Group The Zacks Analyst Blog Highlights: AbbVie, Coherus BioSciences, Bluerock Residential Growth REIT, Huntington Ingalls Industries and Installed Building Products",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recenity": 7
            }
        },
        {
            "time": "2023-04-08",
            "original_text": "Form 8.3 - AbbVie PLC Form 8.3 - AbbVie Inc.",
            "features": {
                "keywords": [
                    "Form 8.3",
                    "AbbVie",
                    "PLC",
                    "Inc."
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "regulatory"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Form 8.3 - AbbVie PLC Form 8.3 - AbbVie Inc.",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 4,
                "Source_Recency": 9
            }
        }
    ]
]